OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

Share

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0